User profiles for G. Archer
Gary ArcherAssistant Professor Duke University Verified email at duke.edu Cited by 10348 |
Staphylococcus aureus: A Well-Armed Pathogen
GL Archer - Reviews of Infectious Diseases, 1998 - academic.oup.com
Staphylococcus aureus is a virulent pathogen that is currently the most common cause of
infections in hospitalized patients. S. aureus infection can involve any organ system. The …
infections in hospitalized patients. S. aureus infection can involve any organ system. The …
Coagulase-negative staphylococci: pathogens associated with medical progress
ME Rupp, GL Archer - Clinical Infectious Diseases, 1994 - JSTOR
… , while most blood cultures are positive, occasional patients will have intermittent bacteremia
but cultures of specimens of the valve ring obtained at surgery will be positive (GL Archer, …
but cultures of specimens of the valve ring obtained at surgery will be positive (GL Archer, …
New mechanisms of bacterial resistance to antimicrobial agents
GA Jacoby, GL Archer - New England Journal of Medicine, 1991 - Mass Medical Soc
Sooner or later bacteria develop resistance to virtually any antimicrobial agent. Resistance
has many consequences. The patient infected with a drug-resistant as opposed to a drug-…
has many consequences. The patient infected with a drug-resistant as opposed to a drug-…
Insights on Evolution of Virulence and Resistance from the Complete Genome Analysis of an Early Methicillin-Resistant Staphylococcus aureus Strain and a Biofilm-Producing …
Staphylococcus aureus is an opportunistic pathogen and the major causative agent of
numerous hospital- and community-acquired infections. Staphylococcus epidermidis has …
numerous hospital- and community-acquired infections. Staphylococcus epidermidis has …
Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus
FC Tenover, R Arbeit, G Archer, J Biddle… - Journal of clinical …, 1994 - Am Soc Microbiol
Fifty-nine Staphylococcus aureus isolates and 1 isolate of Staphylococcus intermedius were
typed by investigators at eight institutions by using either antibiograms, bacteriophage typing…
typed by investigators at eight institutions by using either antibiograms, bacteriophage typing…
[HTML][HTML] Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly …
Purpose Immunologic targeting of tumor-specific gene mutations may allow precise
eradication of neoplastic cells without toxicity. Epidermal growth factor receptor variant III (EGFRvIII) …
eradication of neoplastic cells without toxicity. Epidermal growth factor receptor variant III (EGFRvIII) …
Sensitivity measures, ANOVA-like techniques and the use of bootstrap
GEB Archer, A Saltelli, IM Sobol - Journal of Statistical …, 1997 - Taylor & Francis
… substitution of the sample distribution function G (which places probability mass lln on each
xi) for the unknown population distribution G. Substituting in the function 8(G) above gives …
xi) for the unknown population distribution G. Substituting in the function 8(G) above gives …
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma
…, GE Archer, JE Herndon, DD Bigner, G Dranoff… - Cancer research, 2006 - AACR
Immunosuppression is frequently associated with malignancy and is particularly severe in
patients with malignant glioma. Anergy and counterproductive shifts toward T H 2 cytokine …
patients with malignant glioma. Anergy and counterproductive shifts toward T H 2 cytokine …
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
After stimulation, dendritic cells (DCs) mature and migrate to draining lymph nodes to induce
immune responses 1 . As such, autologous DCs generated ex vivo have been pulsed with …
immune responses 1 . As such, autologous DCs generated ex vivo have been pulsed with …
Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.
…, MR Zalutsky, GN Fuller, GE Archer… - Proceedings of the …, 1990 - National Acad Sciences
We have investigated human gliomas that amplify and rearrange the epidermal growth factor
receptor gene, with generation of an in-frame deletion mutation of 802 nucleotides in the …
receptor gene, with generation of an in-frame deletion mutation of 802 nucleotides in the …